Nature Medicine
9, 510 - 511 (2003)
doi:10.1038/nm0503-510
Mining the genome for combination therapiesTodd R. Golub
Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA Whitehead Institute, MIT Center for Genome Research, Cambridge, Massachusetts, USA Howard Hughes Medical Institute golub@genome.wi.mit.edu
The evaluation of drug combinations for cancer treatment has progressed slowly through methodical clinical research. A new study examining gene expression profiles could signal a shift in the approach to combination therapy.
|
